QA: Cellectar Biosciences Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2020_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001279704')"}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc.

  xvar xval
0 AssetsCurrent 11,385,673
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 435,083
3 remainder_Assets 430,055
4 LiabilitiesCurrent 2,769,758
5 LiabilitiesNoncurrent 421,644
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,182,566
9 ResearchAndDevelopmentExpense 8,996,058
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 85,712
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 12,250,811
1 Liabilities 3,191,402
2 Expenses 14,178,624
3 Revenues 0
4 StockholdersEquity 9,059,409
5 NetIncome -14,092,912
6 ComprehensiveNetIncome -14,092,912
7 BaseVar 14,853,274
8 EconomicCapitalRatio 0.193

Edgar->Model Mapping

Feature Distribution

Change over Time